Light at the end of the tunnel for Illumina?

We have blogged about the Illumina/Grail case and Art. 22 EUMR referrals a few times (here, here and here). Today, the case was in the spotlight again. Advocate General Emiliou delivered his non-binding opinion, finding that the European Commission did not have jurisdiction to block Illumina’s acquisition of Grail. In the following, we will take … Continue reading Light at the end of the tunnel for Illumina?

Forum Shopping

Private cartel damage claims involve careful considerations, especially regarding which court and country to bring the claim to. In Germany, claims may be brought to the defendant’s residence or the place of the harmful event. Recent Dutch court rulings demonstrate a broad interpretation of anchor defendants, raising questions about future trends in European law. Choosing the best court for a claim involves balancing factors such as disclosure claims, damages estimation, and procedural structures, as courts and jurisdictions have developed different approaches in handling private cartel damage claims. Claimants are advised to stay informed of these developments, while potential defendants should prepare accordingly.

An (un-)even playing field: Bias in antitrust cases

Last month, the German Federal Cartel Office (FCO) moved its proceeding concerning the German football league’s “50+1” rule to a different Decision Division. As a result, allegations of bias against the previous case handlers became redundant. A good opportunity to blog about bias in antitrust cases. An unbiased, neutral, and objective judge is one of … Continue reading An (un-)even playing field: Bias in antitrust cases

All eyes on pharma – also in the years to come?

When asked about current trends and industries in the focus of antitrust regulators worldwide, no expert’s shortlist is complete these days without a reference to the pharma industry. The Commission and other EU regulators apparently share that view and recently published a report on what has happened in this sector in the previous years. The … Continue reading All eyes on pharma – also in the years to come?

The Foreign Subsidies Regulation in practice

The European Commission's "FSR brief" highlights the initial 100 days of the Foreign Subsidies Regulation's implementation. Key points include engagement with 53 parties, the application of merger control, and practical guidance for notifications. The brief also offers specific advice for investment funds and mentions the first in-depth investigation involving a Chinese rail company and a Bulgarian government contract.

Private Cartel Damage Claims – Step-by-Step

To companies either being sued as cartelists or claiming compensation as allegedly injured parties, private cartel damage claims are of major economic relevance. While certain steps and processes on the way to claiming damages are prominently on companies’ radars, various other aspects are less known – even though they are just as important. Here is … Continue reading Private Cartel Damage Claims – Step-by-Step

USD 1.2 billion – What tech deal failures have cost acquirers in recent months

Several high-profile tech deals, including Amazon's acquisition of iRobot, were thwarted by merger control scrutiny, resulting in hefty break fees totaling approximately USD 1.2 billion. Break fees, also known as reverse break fees or termination fees, are imposed on acquirers who fail to close pre-agreed acquisitions. The cases underscore the significant costs and complexities of M&A transactions, emphasizing the need for careful assessment of break fees during negotiations.

Digital Cluster Bonn: Germany´s authorities team up

Six German authorities join forces to tackle the challenges of the digitalization era. Kickoff was last week, when the authorities signed a Memorandum of Understanding to initiate the “Digital Cluster Bonn”. Who is in? The reason the new initiative came to my – and probably other antitrust nerd´s – attention is the membership of the … Continue reading Digital Cluster Bonn: Germany´s authorities team up

Access to file: Don’t wait until the end

Access to file is undisputedly one of the essential rights of defense in any cartel investigation. Yet, the when and the extent to which access is granted is often controversially disputed between regulators and alleged cartelists. A recent judgment by a German court strengthens the rights of companies and criticises the established practice by the … Continue reading Access to file: Don’t wait until the end